Global and China Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2027

Global and China Nuclear Medicine/Radiopharmaceutic Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Nuclear Medicine/Radiopharmaceutic Product Introduction
1.2 Market by Type
1.2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Other
1.3 Market by Application
1.3.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size, Estimates and Forecasts
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Revenue 2016-2027
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2027
2.2 Global Nuclear Medicine/Radiopharmaceutic, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Nuclear Medicine/Radiopharmaceutic Historical Market Size by Region (2016-2021)
2.3.1 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Nuclear Medicine/Radiopharmaceutic Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Nuclear Medicine/Radiopharmaceutic Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2022-2027)
2.4.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2022-2027)
3 Global Nuclear Medicine/Radiopharmaceutic Competitor Landscape by Players
3.1 Global Top Nuclear Medicine/Radiopharmaceutic Manufacturers by Sales
3.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturer (2016-2021)
3.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Nuclear Medicine/Radiopharmaceutic Manufacturers by Revenue
3.2.1 Key Nuclear Medicine/Radiopharmaceutic Manufacturers Covered: Ranking by Revenue
3.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2016-2021)
3.2.3 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Nuclear Medicine/Radiopharmaceutic Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Nuclear Medicine/Radiopharmaceutic Revenue in 2020
3.2.6 Global Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Nuclear Medicine/Radiopharmaceutic Price by Manufacturers
3.4 Global Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Product Types
3.4.1 Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
3.4.3 Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Type (2016-2021)
4.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021)
4.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2016-2021)
4.1.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Type (2022-2027)
4.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027)
4.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2022-2027)
4.2.3 Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Nuclear Medicine/Radiopharmaceutic Market Size by Application (2016-2021)
5.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021)
5.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2016-2021)
5.1.3 Nuclear Medicine/Radiopharmaceutic Price by Application (2016-2021)
5.2 Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Application (2022-2027)
5.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027)
5.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2022-2027)
5.2.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2016-2027
6.1.1 China Nuclear Medicine/Radiopharmaceutic Sales YoY Growth 2016-2027
6.1.2 China Nuclear Medicine/Radiopharmaceutic Revenue YoY Growth 2016-2027
6.1.3 China Nuclear Medicine/Radiopharmaceutic Market Share in Global Market 2016-2027
6.2 China Nuclear Medicine/Radiopharmaceutic Market Size by Players (International and Local Players)
6.2.1 China Top Nuclear Medicine/Radiopharmaceutic Players by Sales (2016-2021)
6.2.2 China Top Nuclear Medicine/Radiopharmaceutic Players by Revenue (2016-2021)
6.3 China Nuclear Medicine/Radiopharmaceutic Historic Market Review by Type (2016-2021)
6.3.1 China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
6.3.2 China Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2016-2021)
6.3.3 China Nuclear Medicine/Radiopharmaceutic Price by Type (2016-2021)
6.4 China Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027)
6.4.2 China Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2022-2027)
6.4.3 China Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2022-2027)
6.5 China Nuclear Medicine/Radiopharmaceutic Historic Market Review by Application (2016-2021)
6.5.1 China Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
6.5.2 China Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2016-2021)
6.5.3 China Nuclear Medicine/Radiopharmaceutic Price by Application (2016-2021)
6.6 China Nuclear Medicine/Radiopharmaceutic Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027)
6.6.2 China Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2022-2027)
6.6.3 China Nuclear Medicine/Radiopharmaceutic Price Forecast by Application (2022-2027)
7 North America
7.1 North America Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2016-2027
7.2 North America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
7.2.1 North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021)
7.2.2 North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2016-2027
8.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Region
8.2.1 Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2016-2021)
8.2.2 Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2016-2027
9.2 Europe Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
9.2.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021)
9.2.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2016-2027
10.2 Latin America Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
10.2.1 Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021)
10.2.2 Latin America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Market Facts & Figures by Country
11.2.1 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021)
11.2.2 Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GE Healthcare
12.1.1 GE Healthcare Corporation Information
12.1.2 GE Healthcare Description and Business Overview
12.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
12.1.5 GE Healthcare Recent Development
12.2 Bracco Imaging
12.2.1 Bracco Imaging Corporation Information
12.2.2 Bracco Imaging Description and Business Overview
12.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
12.2.5 Bracco Imaging Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Corporation Information
12.3.2 Mallinckrodt Description and Business Overview
12.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Lantheus Medical Imaging
12.4.1 Lantheus Medical Imaging Corporation Information
12.4.2 Lantheus Medical Imaging Description and Business Overview
12.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Products Offered
12.4.5 Lantheus Medical Imaging Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Description and Business Overview
12.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Nuclear Medicine/Radiopharmaceutic Products Offered
12.5.5 Bayer Recent Development
12.6 Jubilant Pharma
12.6.1 Jubilant Pharma Corporation Information
12.6.2 Jubilant Pharma Description and Business Overview
12.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Products Offered
12.6.5 Jubilant Pharma Recent Development
12.7 Nordion
12.7.1 Nordion Corporation Information
12.7.2 Nordion Description and Business Overview
12.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Nordion Nuclear Medicine/Radiopharmaceutic Products Offered
12.7.5 Nordion Recent Development
12.8 Eli Lilly
12.8.1 Eli Lilly Corporation Information
12.8.2 Eli Lilly Description and Business Overview
12.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Eli Lilly Nuclear Medicine/Radiopharmaceutic Products Offered
12.8.5 Eli Lilly Recent Development
12.9 SIEMENS
12.9.1 SIEMENS Corporation Information
12.9.2 SIEMENS Description and Business Overview
12.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.9.4 SIEMENS Nuclear Medicine/Radiopharmaceutic Products Offered
12.9.5 SIEMENS Recent Development
12.10 China Isotope & Radiation
12.10.1 China Isotope & Radiation Corporation Information
12.10.2 China Isotope & Radiation Description and Business Overview
12.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.10.4 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Products Offered
12.10.5 China Isotope & Radiation Recent Development
12.11 GE Healthcare
12.11.1 GE Healthcare Corporation Information
12.11.2 GE Healthcare Description and Business Overview
12.11.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GE Healthcare Nuclear Medicine/Radiopharmaceutic Products Offered
12.11.5 GE Healthcare Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Nuclear Medicine/Radiopharmaceutic Industry Trends
13.2 Nuclear Medicine/Radiopharmaceutic Market Drivers
13.3 Nuclear Medicine/Radiopharmaceutic Market Challenges
13.4 Nuclear Medicine/Radiopharmaceutic Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Nuclear Medicine/Radiopharmaceutic Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tc-99
Table 3. Major Manufacturers of I-123/131
Table 4. Major Manufacturers of In-111
Table 5. Major Manufacturers of Xe-133
Table 6. Major Manufacturers of Th-201
Table 7. Major Manufacturers of Ga-67
Table 8. Major Manufacturers of Other
Table 9. Global Nuclear Medicine/Radiopharmaceutic Market Size Growth Rate by Application (2021-2027) & (Kiloton)
Table 10. Global Nuclear Medicine/Radiopharmaceutic Market Size by Region (Kiloton) & (US$ Million), 2016 VS 2021 VS 2027
Table 11. Global Nuclear Medicine/Radiopharmaceutic Sales by Regions (2016-2021) & (Kiloton)
Table 12. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Regions (2016-2021)
Table 13. Global Nuclear Medicine/Radiopharmaceutic Revenue by Regions (2016-2021) & (US$ Million)
Table 14. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2022-2027) & (Kiloton)
Table 15. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Region (2022-2027)
Table 16. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 17. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region (2022-2027)
Table 18. Global Nuclear Medicine/Radiopharmaceutic Sales by Manufacturers (2016-2021) (Kiloton)
Table 19. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturers (2016-2021)
Table 20. Ranking of Global Top Nuclear Medicine/Radiopharmaceutic Manufacturers by Revenue (US$ Million) in 2020
Table 21. Nuclear Medicine/Radiopharmaceutic Revenue by Manufacturers (2016-2021) (US$ Million)
Table 22. Nuclear Medicine/Radiopharmaceutic Revenue Share by Manufacturers (2016-2021)
Table 23. Global Nuclear Medicine/Radiopharmaceutic Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 24. Global Nuclear Medicine/Radiopharmaceutic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nuclear Medicine/Radiopharmaceutic as of 2020)
Table 25. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Price (2016-2021) (US$/Ton)
Table 26. Nuclear Medicine/Radiopharmaceutic Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Nuclear Medicine/Radiopharmaceutic Product Type
Table 28. Date of International Manufacturers Enter into Nuclear Medicine/Radiopharmaceutic Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2016-2021) (Kiloton)
Table 31. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2016-2021)
Table 32. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2016-2021) (US$ Million)
Table 33. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2016-2021)
Table 34. Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Type (2016-2021) & (US$/Ton)
Table 35. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2022-2027) & (Kiloton)
Table 36. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type (2022-2027)
Table 37. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast V (2022-2027) & (US$ Million)
Table 38. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Type (2022-2027)
Table 39. Global Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Ton)
Table 40. Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2016-2021) (Kiloton)
Table 41. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2016-2021)
Table 42. Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2016-2021) (US$ Million)
Table 43. Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2016-2021)
Table 44. Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) by Application (2016-2021) & (US$/Ton)
Table 45. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2022-2027) & (Kiloton)
Table 46. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application (2022-2027)
Table 47. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 48. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Application (2022-2027)
Table 49. Global Nuclear Medicine/Radiopharmaceutic Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Ton)
Table 50. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) of Key Companies (2016-2021)
Table 51. China Nuclear Medicine/Radiopharmaceutic Sales Share by Company (2016-2021)
Table 52. China Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) by Company (2016-2021)
Table 53. China Nuclear Medicine/Radiopharmaceutic Revenue Share by Company (2016-2021)
Table 54. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2016-2021)
Table 55. China Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2016-2021)
Table 56. China Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2016-2021)
Table 57. China Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Type (2016-2021)
Table 58. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Type (2022-2027)
Table 59. China Nuclear Medicine/Radiopharmaceutic Sales Share by Type (2022-2027)
Table 60. China Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Type (2022-2027)
Table 61. China Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2022-2027)
Table 62. China Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Type (2022-2027)
Table 63. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2016-2021)
Table 64. China Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2016-2021)
Table 65. China Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2016-2021)
Table 66. China Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Application (2016-2021)
Table 67. China Nuclear Medicine/Radiopharmaceutic Sales (Kiloton) by Application (2022-2027)
Table 68. China Nuclear Medicine/Radiopharmaceutic Sales Share by Application (2022-2027)
Table 69. China Nuclear Medicine/Radiopharmaceutic Revenue (US$ Million) Market Share by Application (2022-2027)
Table 70. China Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2022-2027)
Table 71. China Nuclear Medicine/Radiopharmaceutic Price (US$/Ton) by Application (2022-2027)
Table 72. North America Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 73. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 74. North America Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 75. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 76. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales by Region (2016-2021) & (Kiloton)
Table 77. Asia Pacific Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2016-2021)
Table 78. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue by Region (2016-2021) & (US$ Million)
Table 79. Asia Pacific Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2016-2021)
Table 80. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 81. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 82. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 83. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 84. Latin America Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 85. Latin America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 86. Latin Americaa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 87. Latin America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 88. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2016-2021) & (Kiloton)
Table 89. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2016-2021)
Table 90. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2016-2021) & (US$ Million)
Table 91. Middle East and Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2016-2021)
Table 92. GE Healthcare Corporation Information
Table 93. GE Healthcare Description and Business Overview
Table 94. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 95. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product
Table 96. GE Healthcare Recent Development
Table 97. Bracco Imaging Corporation Information
Table 98. Bracco Imaging Description and Business Overview
Table 99. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 100. Bracco Imaging Product
Table 101. Bracco Imaging Recent Development
Table 102. Mallinckrodt Corporation Information
Table 103. Mallinckrodt Description and Business Overview
Table 104. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 105. Mallinckrodt Product
Table 106. Mallinckrodt Recent Development
Table 107. Lantheus Medical Imaging Corporation Information
Table 108. Lantheus Medical Imaging Description and Business Overview
Table 109. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 110. Lantheus Medical Imaging Product
Table 111. Lantheus Medical Imaging Recent Development
Table 112. Bayer Corporation Information
Table 113. Bayer Description and Business Overview
Table 114. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 115. Bayer Product
Table 116. Bayer Recent Development
Table 117. Jubilant Pharma Corporation Information
Table 118. Jubilant Pharma Description and Business Overview
Table 119. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 120. Jubilant Pharma Product
Table 121. Jubilant Pharma Recent Development
Table 122. Nordion Corporation Information
Table 123. Nordion Description and Business Overview
Table 124. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 125. Nordion Product
Table 126. Nordion Recent Development
Table 127. Eli Lilly Corporation Information
Table 128. Eli Lilly Description and Business Overview
Table 129. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 130. Eli Lilly Product
Table 131. Eli Lilly Recent Development
Table 132. SIEMENS Corporation Information
Table 133. SIEMENS Description and Business Overview
Table 134. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 135. SIEMENS Product
Table 136. SIEMENS Recent Development
Table 137. China Isotope & Radiation Corporation Information
Table 138. China Isotope & Radiation Description and Business Overview
Table 139. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 140. China Isotope & Radiation Product
Table 141. China Isotope & Radiation Recent Development
Table 142. Yantai Dongcheng Biochemicals Corporation Information
Table 143. Yantai Dongcheng Biochemicals Description and Business Overview
Table 144. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2016-2021)
Table 145. Yantai Dongcheng Biochemicals Product
Table 146. Yantai Dongcheng Biochemicals Recent Development
Table 147. Nuclear Medicine/Radiopharmaceutic Market Trends
Table 148. Nuclear Medicine/Radiopharmaceutic Market Drivers
Table 149. Nuclear Medicine/Radiopharmaceutic Market Challenges
Table 150. Nuclear Medicine/Radiopharmaceutic Market Restraints
Table 151. Nuclear Medicine/Radiopharmaceutic Customers List
Table 152. Nuclear Medicine/Radiopharmaceutic Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Nuclear Medicine/Radiopharmaceutic Product Picture
Figure 2. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020 & 2027
Figure 3. Tc-99 Product Picture
Figure 4. I-123/131 Product Picture
Figure 5. In-111 Product Picture
Figure 6. Xe-133 Product Picture
Figure 7. Th-201 Product Picture
Figure 8. Ga-67 Product Picture
Figure 9. Other Product Picture
Figure 10. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020 & 2027
Figure 11. Diagnostic
Figure 12. Therapeutic
Figure 13. Nuclear Medicine/Radiopharmaceutic Report Years Considered
Figure 14. Global Nuclear Medicine/Radiopharmaceutic Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Nuclear Medicine/Radiopharmaceutic Market Size 2016-2027 (US$ Million)
Figure 16. Global Nuclear Medicine/Radiopharmaceutic Sales 2016-2027 (Kiloton)
Figure 17. Global Nuclear Medicine/Radiopharmaceutic Market Size Market Share by Region: 2021 Versus 2027
Figure 18. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2016-2021)
Figure 19. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2020
Figure 20. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2016-2021)
Figure 21. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2020
Figure 22. Global Nuclear Medicine/Radiopharmaceutic Sales Share by Manufacturer in 2020
Figure 23. The Top 10 and 5 Players Market Share by Nuclear Medicine/Radiopharmaceutic Revenue in 2020
Figure 24. Nuclear Medicine/Radiopharmaceutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 25. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2016-2021)
Figure 26. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2020
Figure 27. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2016-2021)
Figure 28. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type in 2020
Figure 29. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2016-2021)
Figure 30. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application in 2020
Figure 31. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2016-2021)
Figure 32. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application in 2020
Figure 33. China Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2027 (Kiloton)
Figure 34. China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2027 (US$ Million)
Figure 35. China Nuclear Medicine/Radiopharmaceutic Market Share in Global Market 2016-2027
Figure 36. China 5 and 10 Largest Nuclear Medicine/Radiopharmaceutic Players Market Share by Revenue in Nuclear Medicine/Radiopharmaceutic in 2020
Figure 37. China Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2016-2021)
Figure 38. China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Type in 2016 & 2020
Figure 39. China Nuclear Medicine/Radiopharmaceutic Revenue Share by Application (2016-2021)
Figure 40. China Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Application in 2016 & 2020
Figure 41. North America Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2021 (Kiloton)
Figure 42. North America Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 43. North America Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2020
Figure 44. North America Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2020
Figure 45. U.S. Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2021) (Kiloton)
Figure 46. U.S. Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Canada Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2016-2021) (Kiloton)
Figure 48. Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2016-2021 (Kiloton)
Figure 50. Europe Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2020
Figure 52. Europe Nuclear Medicine/Radioph

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs